Cargando…
Implications of recent hypertension trials for the generalist physician: whom do we treat, and how?
The publication of the results of the Swedish Trial in Old Patients with Hypertension-2 (STOP-2) and the termination of the doxazocin arm of the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack (ALLHAT) study again raise the question of whether all antihypertensives deliver equa...
| Autor principal: | |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2000
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC59591/ https://www.ncbi.nlm.nih.gov/pubmed/11714401 http://dx.doi.org/10.1186/cvm-1-1-022 |